What is NDC 0143-9230?

0143-9230 is the product NDC for Rifampin, Rifampin 600 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rifampin?

18 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rifampin NDC 0143-9230 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9230Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9230Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9230-01	0014392300100143923001	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0143-9230-01)Marketed from Mar 3, 2016

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rifampin
Generic name (nonproprietary): rifampin
Active ingredients: Rifampin — 600 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205039
Marketing start: Mar 3, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Rifamycins (Chemical structure)
Identifiers: Product ID 0143-9230_1a816eb9-6de4-4751-831b-d183254f36afSPL ID 1a816eb9-6de4-4751-831b-d183254f36afSPL set ID cb59a48c-f66b-4ea0-809c-de0e4be2f8c2RxCUI 312821UNII VJT6J7R4TR
Pharmacologic class: Rifamycin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143923001 followed by a unit qualifier and the quantity

Package 00143-9230-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to Rifampin for Injection, USP and they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to Rifampin for Injection, USP and the patient is not…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9230

What is NDC 0143-9230?: 0143-9230 is the product NDC for Rifampin, Rifampin 600 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rifampin.
What is the active ingredient?: Rifampin.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rifampin?: 18 other product NDCs are listed under this name. See all Rifampin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rifampin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rifampin	Rifampin 150 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-892	70954-0892-1070954-0892-20
Rifampin	Rifampin 300 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-893	70954-0893-1070954-0893-2070954-0893-30
Rifampin	Rifampin 150 mg/1	CapsuleOral	Coupler LLC	67046-1605	67046-1605-03
rifampin	Rifampin 300 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7315	00904-7315-61
Rifampin	Rifampin 150 mg/1	CapsuleOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-801	24658-0801-30
Rifampin	Rifampin 300 mg/1	CapsuleOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-802	24658-0802-60
Rifampin	Rifampin 300 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-799	42806-0799-0142806-0799-0542806-0799-30+1 more
Rifampin	Rifampin 150 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-801	42806-0801-0142806-0801-30
Rifampin	Rifampin 300 mg/1	CapsuleOral	American Health Packaging	60687-586	60687-0586-01
Rifampin	Rifampin 150 mg/1	CapsuleOral	American Health Packaging	60687-575	60687-0575-21

All 19 Rifampin NDCs